Avoiding Scale-Up Surprises: Applying AI and Rapid Prototyping to Media and Process Development

As biologics grow more complex and development timelines continue to tighten, many teams could encounter manufacturability challenges related to decisions around media, process, and scalability made earlier in development. Traditional, sequential workflows may not always surface potential challenges until programs are already moving toward scale-up, which can limit flexibility.

In this webinar, Thermo Fisher Scientific experts discuss factors that contribute to manufacturability challenges during the transition from development to manufacturing. The session walks through a representative development journey, including early insights from AI, data modeling, and analytical testing, followed by media and process development, qualification through rapid prototyping, and considerations for large-scale cGMP manufacturing.

During this session, attendees will hear perspectives on how teams may:
~ Consider manufacturability earlier in biologics development
~ Inform development decisions with AI and data modeling
~ Apply rapid prototyping to evaluate media and process choices
~ Support development decisions prior to cGMP scale-up